Glenmede Trust’s MetLife MET Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.18M | Buy |
44,958
+10,712
| +31% | +$802K | 0.02% | 504 |
|
|
2025
Q4 | $2.7M | Buy |
+34,246
| New | +$2.71M | 0.01% | 522 |
|
|
2025
Q1 | $2.26M | Buy |
28,118
+1,421
| +5% | +$118K | 0.01% | 534 |
|
|
2024
Q4 | $2.19M | Sell |
26,697
-929
| -3% | -$77.3K | 0.01% | 534 |
|
|
2024
Q3 | $2.28M | Buy |
27,626
+809
| +3% | +$60.4K | 0.01% | 542 |
|
|
2024
Q2 | $1.88M | Buy |
26,817
+914
| +4% | +$65.3K | 0.01% | 565 |
|
|
2024
Q1 | $1.92M | Sell |
25,903
-6,336
| -20% | -$442K | 0.01% | 579 |
|
|
2023
Q4 | $2.13M | Buy |
32,239
+4,988
| +18% | +$312K | 0.01% | 548 |
|
|
2023
Q3 | $1.71M | Sell |
27,251
-7,600
| -22% | -$473K | 0.01% | 546 |
|
|
2023
Q2 | $2.02M | Hold |
34,851
| – | – | 0.01% | 513 |
|
|
2023
Q1 | $2.02M | Sell |
34,851
-107,340
| -75% | -$7.24M | 0.01% | 514 |
|
|
2022
Q4 | $10.3M | Sell |
142,191
-152,541
| -52% | -$10.9M | 0.06% | 324 |
|
|
2022
Q3 | $17.9M | Sell |
294,732
-30,055
| -9% | -$1.92M | 0.11% | 196 |
|
|
2022
Q2 | $20.4M | Sell |
324,787
-12,794
| -4% | -$847K | 0.12% | 189 |
|
|
2022
Q1 | $23.7M | Sell |
337,581
-7,995
| -2% | -$541K | 0.12% | 205 |
|
|
2021
Q4 | $21.6M | Buy |
345,576
+15,515
| +5% | +$974K | 0.1% | 234 |
|
|
2021
Q3 | $20.4M | Sell |
330,061
-2,418
| -0.7% | -$146K | 0.11% | 222 |
|
|
2021
Q2 | $19.9M | Sell |
332,479
-29,019
| -8% | -$1.84M | 0.1% | 228 |
|
|
2021
Q1 | $22M | Sell |
361,498
-204,214
| -36% | -$11.3M | 0.12% | 196 |
|
|
2020
Q4 | $26.6M | Buy |
565,712
+34,960
| +7% | +$1.51M | 0.15% | 174 |
|
|
2020
Q3 | $19.7M | Sell |
530,752
-110,900
| -17% | -$4.21M | 0.12% | 196 |
|
|
2020
Q2 | $23.4M | Sell |
641,652
-173,620
| -21% | -$6.04M | 0.14% | 166 |
|
|
2020
Q1 | $41.6M | Hold |
815,272
| – | – | 0.19% | 151 |
|
|
2019
Q4 | $41.6M | Sell |
815,272
-187,330
| -19% | -$9.04M | 0.19% | 151 |
|
|
2019
Q3 | $47.3K | Sell |
1,002,602
-4,058
| -0.4% | -$193K | 0.22% | 124 |
|
|
2019
Q2 | $50K | Sell |
1,006,660
-2,905
| -0.3% | -$137K | 0.22% | 123 |
|
|
2019
Q1 | $43K | Buy |
1,009,565
+12,560
| +1% | +$555K | 0.19% | 152 |
|
|
2018
Q4 | $40.9K | Buy |
997,005
+164,400
| +20% | +$7.05M | 0.2% | 137 |
|
|
2018
Q3 | $38.9M | Buy |
832,605
+7,951
| +1% | +$363K | 0.16% | 212 |
|
|
2018
Q2 | $36M | Buy |
824,654
+433,163
| +111% | +$20.2M | 0.16% | 208 |
|
|
2018
Q1 | $19.8M | Hold |
391,491
| – | – | 0.08% | 308 |
|
|
2017
Q4 | $19.8M | Buy |
391,491
+331,643
| +554% | +$17.5M | 0.08% | 308 |
|
|
2017
Q3 | $3.11M | Sell |
59,848
-1,534
| -2% | -$74.7K | 0.01% | 574 |
|
|
2017
Q2 | $2.89M | Hold |
61,382
| – | – | 0.01% | 580 |
|
|
2017
Q1 | $2.89M | Sell |
61,382
-136,006
| -69% | -$6.48M | 0.01% | 580 |
|
|
2016
Q4 | $9.48M | Buy |
197,388
+33,951
| +21% | +$1.56M | 0.05% | 364 |
|
|
2016
Q3 | $6.47M | Buy |
163,437
+9,772
| +6% | +$367K | 0.04% | 434 |
|
|
2016
Q2 | $5.45M | Sell |
153,665
-635
| -0.4% | -$24.8K | 0.03% | 443 |
|
|
2016
Q1 | $6.04M | Sell |
154,300
-483,645
| -76% | -$18.1M | 0.04% | 408 |
|
|
2015
Q4 | $27.4M | Buy |
637,945
+12,653
| +2% | +$556K | 0.19% | 163 |
|
|
2015
Q3 | $26.3M | Buy |
625,292
+396,588
| +173% | +$18.5M | 0.19% | 165 |
|
|
2015
Q2 | $11.4M | Buy |
228,704
+49,175
| +27% | +$2.33M | 0.08% | 333 |
|
|
2015
Q1 | $8.09M | Sell |
179,529
-22,862
| -11% | -$1.03M | 0.06% | 384 |
|
|
2014
Q4 | $9.76M | Buy |
202,391
+187,609
| +1,269% | +$8.91M | 0.08% | 347 |
|
|
2014
Q3 | $705K | Sell |
14,782
-8,863
| -37% | -$431K | 0.01% | 778 |
|
|
2014
Q2 | $1.17M | Buy |
23,645
+9,132
| +63% | +$427K | 0.01% | 655 |
|
|
2014
Q1 | $680K | Sell |
14,513
-3,284
| -18% | -$151K | 0.01% | 789 |
|
|
2013
Q4 | $854K | Sell |
17,797
-3,668
| -17% | -$164K | 0.01% | 716 |
|
|
2013
Q3 | $896K | Sell |
21,465
-6,560
| -23% | -$283K | 0.01% | 679 |
|
|
2013
Q2 | $1.14M | Buy |
+28,025
| New | +$1.03M | 0.01% | 607 |
|
Other funds holding MET
VCM
VPM
Glenmede Trust's MET Position: Q1 2026 in Review
Glenmede Trust increased its MetLife (MET) stake by 31% in Q1 2026, buying an estimated $802K and bringing the position to 44,958 shares worth $3.18M. The position accounts for 0.02% of the portfolio, ranked #504.
Glenmede Trust first reported a position in MET in Q2 2013 and has held it in 50 quarters since. The position peaked at $41.6M in Q1 2020. 1,371 funds tracked by Wall St. Rank hold MET as of Q1 2026.
- Glenmede Trust held 44,958 shares of MetLife worth $3.18M as of Q1 2026.
- Glenmede Trust bought 10,712 MetLife shares in Q1 2026, an estimated $802K.
- MetLife made up 0.02% of Glenmede Trust's portfolio in Q1 2026, its #504 holding.
- Glenmede Trust first reported a position in MetLife in Q2 2013 and has held it in 50 quarters since.
- Glenmede Trust's MetLife position peaked at $41.6M in Q1 2020.
- 1,371 funds tracked by Wall St. Rank held MetLife as of Q1 2026.
Based on Glenmede Trust's 13F filing for Q1 2026, filed 26 May 2026.